Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Translational Medicine|April 30, 2023
Strengths and limitations of new artificial intelligence tool for rare disease epidemiologyDavid Lapidus
Frontiers in Pediatrics|January 26, 2024
An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussionRyan Colburn, David Lapidus
Molecular Genetics and Metabolism|June 30, 2017
Newborn screening for hyperargininemia due to arginase 1 deficiencyBradford L Therrell, Robert Currier, David Lapidus, et al.
Orphanet Journal of Rare Diseases|August 6, 2021
Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organizationRobert J Pignolo, Edward C Hsiao, Genevieve Baujat, et al.
Molecular Genetics and Metabolism|February 15, 2020
Estimated prevalence of moderate to severely elevated total homocysteine levels in the United States: A missed opportunity for diagnosis of homocystinuria?Marcia Sellos-Moura, Frank Glavin, David Lapidus, et al.
Hormone Research in Paediatrics|June 17, 2024
The Birth Prevalence of Congenital Hyperinsulinism: A Narrative Review of the Epidemiology of a Rare DiseaseDavid Lapidus, Diva D De León, Paul S Thornton, et al.
Autism Research : Official Journal of the International Society for Autism Research|June 29, 2026
Prevalence of Phelan McDermid Syndrome Estimated To Be ~1:7300 Using a Multisource ModelTess Levy, David Lapidus, Kate Friedman, et al.
Orphanet Journal of Rare Diseases|July 2, 2017
Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databasesGeneviève Baujat, Rémy Choquet, Stéphane Bouée, et al.
Pageof 1